Benzodrocortisone, also known as hydrocortisone 17-benzoate, is a synthetic glucocorticoid corticosteroid which was assigned an INNTooltip International Nonproprietary Name in 2016, and has yet to be marketed.[1]

Benzodrocortisone
Clinical data
Other namesHydrocortisone 17-benzoate; 11β,17α,21-Trihydroxypregn-4-ene-3,20-dione 17-benzoate; 17α-Benzoyloxypregn-4-ene-11α-ol-3,20-dione
Drug classCorticosteroid; Glucocorticoid
Identifiers
  • [(8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] benzoate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC28H34O6
Molar mass466.574 g·mol−1
3D model (JSmol)
  • C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)OC(=O)C5=CC=CC=C5)C)O
  • InChI=1S/C28H34O6/c1-26-12-10-19(30)14-18(26)8-9-20-21-11-13-28(23(32)16-29,27(21,2)15-22(31)24(20)26)34-25(33)17-6-4-3-5-7-17/h3-7,14,20-22,24,29,31H,8-13,15-16H2,1-2H3/t20-,21-,22-,24+,26-,27-,28-/m0/s1
  • Key:LPEYMYDYPGRLBU-YGZHYJPASA-N

References

edit
  1. ^ World Health Organization (2016). "Proposed INN: List 116" (PDF). World Health Organization. Retrieved 2017-07-03.